Sort   by:  
 Page size 
PARP Inhibition Exacerbates Tumor-autonomous Immunogenicity Driven by BRCA1 Deficiency through DNA Sensing and Interferon Response in Ovarian Cancer
Genomics
BRCA1 and TP53 Co-Deficiency Causes a PARP-inhibitor Sensitive Erythroproliferative Neoplasm
Sort   by:  
 Page size